MX2016007148A - Metodos de ensayo de beta-glucano. - Google Patents

Metodos de ensayo de beta-glucano.

Info

Publication number
MX2016007148A
MX2016007148A MX2016007148A MX2016007148A MX2016007148A MX 2016007148 A MX2016007148 A MX 2016007148A MX 2016007148 A MX2016007148 A MX 2016007148A MX 2016007148 A MX2016007148 A MX 2016007148A MX 2016007148 A MX2016007148 A MX 2016007148A
Authority
MX
Mexico
Prior art keywords
subject
glucan
biomarker
sample
rau
Prior art date
Application number
MX2016007148A
Other languages
English (en)
Inventor
BOSE Nandita
A Antonysamy Mary
B Gorden Keith
Walsh Richard
E Danielson Michael
Maimonis Peter
Original Assignee
Biothera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biothera Inc filed Critical Biothera Inc
Publication of MX2016007148A publication Critical patent/MX2016007148A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta descripción proporciona, en un aspecto, un método para analizar una muestra a partir de un sujeto para un biomarcador que es indicativo de la respuesta inmunológica del sujeto a beta-glucano. Generalmente, el método incluye obtener una muestra biológica de un sujeto, analizar la muestra por un anticuerpo anti-beta-glucano biomarcador comparado con un estándar de referencia, computar un valor de unidad de anticuerpo relativo (RAU por sus siglas en inglés) para anticuerpo anti-beta-glucano en la muestra, e identificar el sujeto como biomarcador positivo si el valor RAU es mayor que un valor RAU predeterminado para el anticuerpo anti-beta-glucano biomarcador.
MX2016007148A 2013-12-05 2014-12-01 Metodos de ensayo de beta-glucano. MX2016007148A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361912275P 2013-12-05 2013-12-05
US201462005335P 2014-05-30 2014-05-30
PCT/US2014/067944 WO2015084732A1 (en) 2013-12-05 2014-12-01 β-GLUCAN ASSAY METHODS

Publications (1)

Publication Number Publication Date
MX2016007148A true MX2016007148A (es) 2016-12-07

Family

ID=53274006

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007148A MX2016007148A (es) 2013-12-05 2014-12-01 Metodos de ensayo de beta-glucano.

Country Status (12)

Country Link
US (3) US9885726B2 (es)
EP (1) EP3077816B1 (es)
JP (1) JP6673829B2 (es)
CN (1) CN106170698A (es)
AU (1) AU2014357446B2 (es)
CA (1) CA2932192C (es)
EA (1) EA201691168A1 (es)
ES (1) ES2874057T3 (es)
IL (1) IL245913A0 (es)
MX (1) MX2016007148A (es)
NZ (1) NZ720608A (es)
WO (1) WO2015084732A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2643331C2 (ru) * 2012-04-30 2018-01-31 Байотера, Инк. Способы бета-глюкановой иммунотерапии
US11815435B2 (en) * 2017-02-24 2023-11-14 Hibercell, Inc. Beta glucan immunopharmacodynamics
US20210283168A1 (en) 2018-03-13 2021-09-16 Hibercell, Inc. Beta glucan and cd40 agonist combination immunotherapy
CN112424602B (zh) * 2018-07-27 2024-09-06 积水医疗株式会社 生物样品中(1→3)-β-D-葡聚糖的免疫分析方法、(1→3)-β-D-葡聚糖分析试剂盒以及(1→3)-β-D-葡聚糖免疫分析方法中使用的生物样品碱性预处理溶液
EP3936522B1 (en) * 2019-03-08 2025-01-08 Sekisui Medical Co., Ltd. METHOD FOR IMMUNOLOGIC ANALYSIS OF ß-D-GLUCAN IN BIOLOGICAL SAMPLE, AND ß-D-GLUCAN ANALYSIS KIT

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084092A (en) 1997-01-31 2000-07-04 The Collaborative Group, Ltd. β(1-3)-glucan diagnostic assays
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
EP1539194A4 (en) * 2002-09-04 2007-06-13 Univ Louisville Res Found CANCER THERAPY WITH BETA-GLUCAN AND ANTIBODIES
SE0203116D0 (sv) * 2002-10-21 2002-10-21 Tremedic Internat Ab Antibodies reactive with beta-glucons
US8450079B2 (en) * 2003-10-31 2013-05-28 Immunetics, Inc. Method for detecting bacteria
JP4666284B2 (ja) * 2005-11-30 2011-04-06 味の素株式会社 グルカン感受性予測方法、グルカン感受性増強剤及びそのスクリーニング方法
JP4795037B2 (ja) * 2006-02-01 2011-10-19 財団法人 神戸市地域医療振興財団 川崎病の判定方法及びそのためのキット
EP2032180B1 (en) 2006-06-15 2017-03-15 Biothera, Inc. Glucan preparations
AU2013203785B2 (en) * 2006-11-06 2016-11-17 Immunexcite, Inc. Immunomodulating compositions and methods of use thereof
AU2009243094B2 (en) 2006-11-06 2015-02-12 Massachusetts Institute Of Technology Immunomodulating compositions and methods of use thereof
JP4979467B2 (ja) * 2006-12-05 2012-07-18 尚仁 大野 抗β−グルカン抗体測定方法と測定キット
JP5054425B2 (ja) * 2007-05-07 2012-10-24 尚仁 大野 抗β−１，６−グルカン・モノクローナル抗体
MX2009012070A (es) 2007-05-08 2009-12-08 Biopolymer Engineering Inc Dba Preparacion de glucano soluble en particulas.
JP5686308B2 (ja) * 2009-02-20 2015-03-18 国立大学法人広島大学 βグルカンの濃度測定方法および濃度測定用キット
KR20110137337A (ko) * 2009-03-06 2011-12-22 모찌다 세이야쿠 가부시끼가이샤 자궁 내막증의 판정 방법 및 자궁 내막증의 진단용 키트
WO2010107068A1 (ja) 2009-03-17 2010-09-23 和光純薬工業株式会社 β－グルカンの測定方法及びそれに用いられるβ－グルカン結合性蛋白質
JP5487393B2 (ja) * 2009-03-31 2014-05-07 静岡県 ＥＬＩＳＡ法を用いたヒト血清中の抗原特異的なＩｇＧ抗体力価測定の標準化法
JP5633721B2 (ja) * 2009-10-30 2014-12-03 国立大学法人徳島大学 乳幼児のアレルギー発症を予測するためのデータを提供する方法
US20140228543A1 (en) 2011-05-06 2014-08-14 Biothera, Inc. MODIFIED AND DERIVATIZED ß-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODS
FI123866B (en) * 2012-02-03 2013-11-29 Thermo Fisher Scientific Oy Method for determining beta-D-glucan levels
RU2643331C2 (ru) * 2012-04-30 2018-01-31 Байотера, Инк. Способы бета-глюкановой иммунотерапии
CN102866255B (zh) 2012-09-13 2014-12-24 莫水晶 一种人体液真菌(1,3)-β-D葡聚糖检测试剂盒及其应用方法
CN103235116B (zh) * 2013-04-13 2015-06-03 福州大学 一种抗体标记信号或核酸探针标记信号放大的方法

Also Published As

Publication number Publication date
US9885726B2 (en) 2018-02-06
WO2015084732A1 (en) 2015-06-11
CA2932192C (en) 2020-10-06
AU2014357446A1 (en) 2016-06-16
IL245913A0 (en) 2016-07-31
EP3077816B1 (en) 2021-03-24
CA2932192A1 (en) 2015-06-11
AU2014357446B2 (en) 2020-05-07
NZ720608A (en) 2022-11-25
ES2874057T3 (es) 2021-11-04
JP2017501399A (ja) 2017-01-12
US20160305955A1 (en) 2016-10-20
JP6673829B2 (ja) 2020-03-25
EP3077816A1 (en) 2016-10-12
US20190064179A1 (en) 2019-02-28
US10114027B2 (en) 2018-10-30
EA201691168A1 (ru) 2016-11-30
CN106170698A (zh) 2016-11-30
EP3077816A4 (en) 2017-06-21
US20180128836A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
MX366275B (es) Metodos para detectar y medir la agregacion.
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
MY198335A (en) Urinalysis Device and Dry Reagent for Quantitative Urinalysis
BR112016021493A2 (pt) método de processamento de dados de ritmo cardíaco, produto de programa de computador e sistema para processamento de dados de ritmo cardíaco
EP2839266A4 (en) METHOD AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE
HK1223361A1 (zh) 用於预测肠易激综合征诊断的途径特异性测定
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
GB2519906A (en) Methods and systems for detecting biological components
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
EP4513499A3 (en) Method and device for analyzing target analyte in sample
MX2016007148A (es) Metodos de ensayo de beta-glucano.
EP2950099A4 (en) PROCESS FOR PREPARING A SAMPLE FOR THE DETECTION OF HBS ANTIGEN AND USE THEREOF
EP2962105A4 (en) METHOD AND REAGENTS FOR DETERMINING ISOMERIC ANALYTES
MX376501B (es) Adn huésped como biomarcador de la enfermedad de crohn.
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
MX2015004419A (es) Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables.
IN2013CH05587A (es)
MX384485B (es) Deteccion temprana de preeclampsia.
MX2015015023A (es) Metodo para la determinacion de cobre libre.
SG10201901836PA (en) Test strip assembly
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
MX2017008748A (es) Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana.
MY194325A (en) Test object detection method, and immunoassay instrument and monoclonal antibody for same